Abstract
It has remarkable efficacy to treat cervical cancer cell using beta-sitosterol. At present, beta-sitosterol has been used in the clinical treatment of cancer and its side effects are remotely lower than the traditional drug such as cisplatin. However, the anticancer mechanism of beta-sitosterol is unknown in cervical cancer. In this study, we mainly use TaqMan MicroRNA Assay to detect the consequence of Hela cell treatment by beta-sitosterol and cisplatin and analyze it from molecular level. We find out the differentially expressed microRNAs and forecast their targets by Targetscan. We also provide direct evidence that STK4/MST1 is a functional target. From the viewpoint of bioinformatics, we speculate the possible pathway of beta-sitosterol to inhibit tumor.
| Original language | English |
|---|---|
| Title of host publication | Proceedings - 2012 IEEE International Conference on Bioinformatics and Biomedicine Workshops, BIBMW 2012 |
| Pages | 824-830 |
| Number of pages | 7 |
| DOIs | |
| Publication status | Published - 2012 |
| Externally published | Yes |
| Event | 2012 IEEE International Conference on Bioinformatics and Biomedicine Workshops, BIBMW 2012 - Philadelphia, PA, United States Duration: 4 Oct 2012 → 7 Oct 2012 |
Publication series
| Name | Proceedings - 2012 IEEE International Conference on Bioinformatics and Biomedicine Workshops, BIBMW 2012 |
|---|
Conference
| Conference | 2012 IEEE International Conference on Bioinformatics and Biomedicine Workshops, BIBMW 2012 |
|---|---|
| Country/Territory | United States |
| City | Philadelphia, PA |
| Period | 4/10/12 → 7/10/12 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- STK4/MST1
- beta-sitosterol
- hela
- microarray
Fingerprint
Dive into the research topics of 'Integrated analysis of hela cell microRNAs' microarray data and anti-cancer pathway prediction of beta-sitosterol'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver